|
PNP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.09008415814105E-12 |
| Normal-vs-Stage2 |
1.015040E-03 |
| Normal-vs-Stage3 |
1.88229998254741E-09 |
| Normal-vs-Stage4 |
1.523700E-03 |
| Stage1-vs-Stage2 |
1.612190E-01 |
| Stage1-vs-Stage3 |
8.262400E-01 |
| Stage1-vs-Stage4 |
2.154200E-01 |
| Stage2-vs-Stage3 |
1.632420E-01 |
| Stage2-vs-Stage4 |
6.948200E-02 |
| Stage3-vs-Stage4 |
2.565400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
2.042900E-04 |
| Normal-vs-Asian |
1.840230E-04 |
| Caucasian-vs-AfricanAmerican |
4.00140000023086E-07 |
| Caucasian-vs-Asian |
2.212000E-01 |
| AfricanAmerican-vs-Asian |
3.871600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.97368854172009E-12 |
| Normal-vs-Female |
1.67232894199287E-12 |
| Male-vs-Female |
9.701400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.9327000000402E-08 |
| Normal-vs-Age(41-60Yrs) |
3.78352904562007E-12 |
| Normal-vs-Age(61-80Yrs) |
1.985540E-04 |
| Normal-vs-Age(81-100Yrs) |
1.321150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.675000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.010000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.212200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.081000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.480800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.618200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.823840E-02 |
| Classical-VS-Follicular |
4.89200013831237E-10 |
| Classical-VS-Other |
9.268800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
7.802500E-04 |
| Tall-VS-Other |
3.746100E-02 |
| Tall-VS-Normal |
3.429700E-04 |
| Follicular-VS-Other |
1.407580E-01 |
| Follicular-VS-Normal |
3.170200E-02 |
| Other-VS-Normal |
7.455700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.59280000195028E-08 |
| Normal-vs-N1 |
1.56226999999953E-05 |
| N0-vs-N1 |
1.492040E-01 |
|
|
